Literature DB >> 1400898

Indeterminate western blot patterns in a cohort of individuals at high risk for human immunodeficiency virus (HIV-1) exposure.

R T Davey1, L R Deyton, J A Metcalf, M Easter, J A Kovacs, M Vasudevachari, M Psallidopoulos, L M Thompson, J Falloon, M A Polis.   

Abstract

Our objective was to map serial patterns of Western blot reactivity over time of a cohort of initially ELISA-negative, Western blot-indeterminate individuals from a high-risk group and to determine if these individuals were at increased risk of harboring occult HIV-1 infection. A 2-year prospective study used serial ELISA, two types of Western blot, immunologic profiles, HIV-1 culture, and analysis by polymerase chain reaction. Subjects were 20 ELISA-negative, Western blot indeterminate homosexual volunteers and 20 matched seronegative controls. Results showed that 19 of 20 study subjects completed a mean of 17.0 months of clinical and laboratory follow-up. Reactivities with p24 and/or with p55 were the two most commonly observed Western blot patterns, occurring in 70% of individuals. Specific Western blot reactivity was dependent upon the particular immunoblot preparation being used and varied considerably on a longitudinal basis. No individual pattern appeared predictive of an increased likelihood of subsequent seroconversion to HIV-1 relative to controls. By all other criteria including polymerase chain reaction analysis, samples from 17 of 19 individuals remained negative for HIV-1 at each time point. Two individuals evolved from an indeterminate to a positive Western blot and, simultaneously, from a negative to a positive polymerase chain reaction analysis, during follow-up. Our conclusions were as follows. ELISA-negative, Western blot-indeterminate individuals from a high-risk group show marked variability in immunoblot findings over time, and these patterns do not appear predictive of an increased likelihood of infection.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1400898     DOI: 10.1007/bf00918087

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  23 in total

1.  What do western blot indeterminate patterns for human immunodeficiency virus mean in EIA-negative blood donors?

Authors:  J Genesca; J W Shih; B W Jett; I K Hewlett; J S Epstein; H J Alter
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321

2.  Duration of human immunodeficiency virus infection before detection of antibody.

Authors:  C R Horsburgh; C Y Ou; J Jason; S D Holmberg; I M Longini; C Schable; K H Mayer; A R Lifson; G Schochetman; J W Ward
Journal:  Lancet       Date:  1989-09-16       Impact factor: 79.321

3.  Human immunodeficiency virus type 1 infection in homosexual men who remain seronegative for prolonged periods.

Authors:  D T Imagawa; M H Lee; S M Wolinsky; K Sano; F Morales; S Kwok; J J Sninsky; P G Nishanian; J Giorgi; J L Fahey
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

4.  Serological diagnosis of human immunodeficiency virus infection by Western blot testing. The Consortium for Retrovirus Serology Standardization.

Authors: 
Journal:  JAMA       Date:  1988-08-05       Impact factor: 56.272

Review 5.  The western immunoblot procedure for HIV antibodies and its interpretation.

Authors:  R Y Dodd; C T Fang
Journal:  Arch Pathol Lab Med       Date:  1990-03       Impact factor: 5.534

6.  Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening. The Transfusion Safety Study/NHLBI Donor Repository.

Authors:  S H Kleinman; J C Niland; S P Azen; E A Operskalski; L H Barbosa; A I Chernoff; V M Edwards; B A Lenes; G J Marshall; G J Nemo
Journal:  Transfusion       Date:  1989-09       Impact factor: 3.157

Review 7.  The significance of HIV-1-indeterminate western blot results in blood donor populations.

Authors:  S Kleinman
Journal:  Arch Pathol Lab Med       Date:  1990-03       Impact factor: 5.534

8.  Long latency precedes overt seroconversion in sexually transmitted human-immunodeficiency-virus infection.

Authors:  A Ranki; S L Valle; M Krohn; J Antonen; J P Allain; M Leuther; G Franchini; K Krohn
Journal:  Lancet       Date:  1987-09-12       Impact factor: 79.321

9.  Evaluation of human immunodeficiency virus seroprevalence in population surveys using pooled sera.

Authors:  R L Kline; T A Brothers; R Brookmeyer; S Zeger; T C Quinn
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

10.  Integrated proviral human immunodeficiency virus type 1 is present in CD4+ peripheral blood lymphocytes in healthy seropositive individuals.

Authors:  M C Psallidopoulos; S M Schnittman; L M Thompson; M Baseler; A S Fauci; H C Lane; N P Salzman
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

View more
  1 in total

Review 1.  The epidemiology and transmission of AIDS: a hypothesis linking behavioural and biological determinants to time, person and place.

Authors:  G T Stewart
Journal:  Genetica       Date:  1995       Impact factor: 1.082

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.